Targeting epigenetic modifiers offers potential therapeutic applications. DNMT inhibitors, HDAC inhibitors, and drugs targeting specific histone modifications are being investigated for treating various diseases. These therapies aim to reverse aberrant epigenetic marks and restore normal gene expression patterns.
